Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: Facts and unsolved questions

Clinical Endocrinology

Volumn 69, Issue 6, 2008, Pages 845-847

  Tanda, Maria Laura ^a   Lai, Adriana ^a   Bartalena, Luigi ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; GLUCOCORTICOID; LEVOTHYROXINE; PREDNISONE; RADIOACTIVE IODINE; THYROTROPIN RECEPTOR ANTIBODY;

CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE CONTROL; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; ENDOCRINE OPHTHALMOPATHY; ENVIRONMENTAL FACTOR; EUTHYROIDISM; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; NOTE; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REMISSION; SMOKING CESSATION; THYROIDECTOMY; TREATMENT DURATION;

GRAVES OPHTHALMOPATHY; HUMANS; HYPERTHYROIDISM; RADIOTHERAPY;

EID: 55949128489     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03417.x     Document Type: Note

References (21)

1. Bartalena, L., Pinchera. A. Marcocci, C. (2000) Management of Graves' ophthalmopathy: reality and perspectives. Endocrine Reviews, 21, 168 199.
2. Wiersinga, W.M. Bartalena, L. (2002) Epidemiology and prevention of Graves' ophthalmopathy. Thyroid, 12, 855 860.
3. Tallstedt, L., Lundell, G., Torring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., Taube, A. the Thyroid Study Group (1992) Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. New England Journal of Medicine, 326, 1733 1738.
4. Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M.L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M.P., Lepri, A., Rossi, G., Martino, E. Pinchera, A. (1998) Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. New England Journal of Medicine, 338, 73 78.
5. Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G. Torring, O. (2008) TSH-receptor autoimmunity in Graves'disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. European Journal of Endocrinology, 168, 69 75.
6. Weetman, A. Wiersinga, W.M. (1998) Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey. Clinical Endocrinology, 49, 21 28.
7. Wiersinga, W.M. (1998) Preventing Graves' ophthalmopathy. New England Journal of Medicine, 338, 121 122.
8. Menconi, F., Marinò, M., Pinchera, A., Rocchi, R., Mazzi, B., Nardi, M., Bartalena, L. Marcocci, C. (2007) Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. Journal of Clinical Endocrinology and Metabolism, 92, 1653 1658.
9. Bartalena, L., Marcocci, C., Lai, A. Tanda, M.L. (2008) Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid? Journal of Endocrinological Investigation, 31, 578 581.
10. Bartalena, L., Baldeschi, L., Dickinson, A., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M., Perros, P., Boboridis, K., Boschi, A., Currò, N., Daumerie, C., Kahaly, G.J., Krassas, G.E., Lane, C.M., Lazarus, J.H., Marinò, M., Nardi, M., Neoh, C., Orgiazzi, J., Pearce, S., Pinchera, A., Pitz, S., Salvi, M., Sivelli, P., Stahl, M., von Arx, G. Wiersinga, W.M. (2008) Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of GO. European Journal of Endocrinology, 158, 273 285.
11. Bartalena, L., Baldeschi, L., Dickinson, A.J., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M.P., Perros, P., Boboridis, K., Boschi, A., Currò, N., Daumerie, C., Kahaly, G.J., Krassas, G.E., Lane, C.M., Lazarus, J.H., Marinò, M., Nardi, M., Neoh, C., Orgiazzi, J., Pearce, S., Pinchera, A., Pitz, S., Salvi, M., Sivelli, P., Stahl, M., von Arx, G. Wiersinga, W.M. (2008) Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' Orbitopathy. Thyroid, 18, 333 346.
12. Acharya, S.H., Avenell, A., Philip, S., Burr, J., Bevan, J.S. Abraham, P. (2008) Radioiodine therapy for Graves' disease and the effect on ophthalmopathy - a systematic review. Clinical Endocrinology, 69, 943 950.
13. Bartalena, L., Marcocci, C., Tanda, M.L., Manetti, L., Dell'Unto, E., Bartolomei, M.P., Nardi, M., Martino, E. Pinchera, A. (1998) Cigarette smoking and treatment outcomes in Graves' ophthalmopathy. Annals of Internal Medicine, 129, 632 635.
14. Tallstedt, L., Lundell, G., Blomgren, H. Bring, J. (1994) Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? European Journal of Endocrinology, 130, 494 497.
15. Prummel, M.F., Wiersinga, W.M., Mourits, M.P., Koornneef, L., Berghout, A. van der Gaag, R. (1990) Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Archives of Internal Medicine, 150, 1098 1101.
16. Eckstein, A.K., Plicht, M., lax, H., Neuhauser, M., Mann, K., Lederbogen, S., Heckmann, C., Esser, J. Morgenthaler, N.G. (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. Journal of Clinical Endocrinology and Metabolism, 91, 3464 3470.
17. Schott, M., Morgenthaler, N.G., Fritzen, R., Fledkamp, J., Willenberg, H.S., Scherbaum, W.A. Seissler, J. (2004) Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. Hormone and Metabolic Research, 36, 92 96.
18. Eckstein, A.K., Lax, H., Losch, C., Glowacka, D., Plicht, M., Mann, K., Esser, J. Morgenthaler, N.G. (2006) Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission. Clinical Endocrinology, 67, 607 612.
19. Perros, P., Kendall-Taylor, P., Neoh, C., Frewins, S. Dickinson, J. (2005) A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism, 90, 5321 5323.
20. Bartalena, L., Marcocci, C., Bogazzi, F., Panicucci, M., Lepri, A. Pinchera, A. (1989) Use of corticosteroids to prevent progression of Graves' ophthalmopathy after treatment for Graves' hyperthyroidism. New England Journal of Medicine, 321, 1349 1352.
21. Vaidya, B., Williams, G.R., Abraham, P. Pearce, S.H.S. (2008) Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists. Clinical Endocrinology, 68, 814 820.